Swaziland

Swaziland country outline

Estimated Number of Current PrEP Users

200-400

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

3,000-3,500

PEPFAR Target in COP 2017

1,300

Types of Delivery Projects

  • Demonstration projects
  • Implementation projects
  • Large-scale implementation initiative

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC are not approved for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned research/demonstration projects in Swaziland.

Policy Framework

N/A

Funding

USAID, The Bill & Melinda Gates Foundation, PEPFAR, Nike Foundation, Heidelberg Institute of Public Health, Mylan


Eligibility Criteria
Resources for Swaziland
Glossary of Terms

Last updated April 16, 2018.

News Spotlight

  • PrEPcost.org Launches

    November 8, 2017

    This site matches individuals who are interested in PrEP to eligible health plans and provides comparative pricing. PrEPcost.org is designed for both PrEP users and health care providers to make it easy to navigate the insurance options and find the best plans available.

    Read more